ESTRO 2025 - Abstract Book

S4170

RTT - Patient experience and quality of life

ESTRO 2025

not subside after cancer treatment. People living with and beyond a cancer diagnosis have highlighted the lack of available services to support them to manage these late effects. The aim of this project was to identify, geographically, the prevalence of any late effects services provided by the NHS across the UK. The primary services to be evaluated were that are available to adults living with and beyond cancer. Material/Methods: Initially a questionnaire was circulated via stakeholder organisations i.e. NHS Trusts, third sector and people with lived experience of late effects to identify any and every current late effects service across the UK. This was followed by specific tumour group mapping, identifying referral criteria, and identifying need within specific regions. Results: During a 3-month period, 34 responses were received, finding 41 adult services across the UK: 1 in Northern Ireland, 1 in Scotland, 3 in Wales and 36 in England, of which: 14 has been initially funded by Macmillan Cancer Support charity. Within the UK, 18 specifically for radiotherapy, 15 only for pelvic related effects, only 2 for head and neck and 2 for immunotherapy were found during the time period utilised. Of these, 20 services are therapeutic radiographer led, while 15 are nurse led. Conclusion: Late effects and consequences of treatment have a large burden on patients living with and beyond cancer. This mapping exercise has identified vast gaps across the UK. It has highlighted what is available for all tumour sites and which areas we need to focus with an aim of reducing the burden on A&Es across the UK. Much more needs to be done to keep up with the demand of future late effects requirements.

Keywords: Late Effects

1822

Digital Poster Development Of A Mobile App To Provide Tailored Symptom Management Feedback To Prostate Cancer

Patients Undergoing Radiotherapy Claudia Barrias Aradas, Susan Mercieca Radiography Department, Faculty of Health Sciences, University of Malta, Msida, Malta

Purpose/Objective: Prostate cancer patients undergoing radiotherapy often experience various side effects, including urinary, gastrointestinal, and sexual dysfunction, which significantly impact their quality of life [1]. Limited resources and time constraints can hinder healthcare professionals' (HCPs) ability to record these treatment-related side effects in a structured format and deliver timely and effective interventions tailored to individual needs. Mobile apps offer an opportunity to provide tailored, real-time symptom management feedback to enhance patient engagement and care between clinical visits. This study aimed to develop a mobile app to facilitate the reporting and self management of radiotherapy-induced side effects for prostate cancer patients undergoing radiotherapy. Material/Methods: The study was divided into 3 phases. The first phase involved a consultation with 3 radiographers to inform the content and design of the mobile application. Based on the findings of the consultation process and literature [1] a self-reporting side-effect management tool was developed and integrated into an existing mobile application AssistRT. [2]. The AssistRT app was integrated with a web-based platform called AssistMDT that HCPs could use to monitor the patient's symptoms. In the final phase of the study, 4 radiographers and 1 oncologist were asked to